GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » EV-to-EBIT
中文

Simulations Plus (Simulations Plus) EV-to-EBIT

: 64.97 (As of Today)
View and export this data going back to 1997. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Simulations Plus's Enterprise Value is $791.65 Mil. Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $12.19 Mil. Therefore, Simulations Plus's EV-to-EBIT for today is 64.97.

The historical rank and industry rank for Simulations Plus's EV-to-EBIT or its related term are showing as below:

SLP' s EV-to-EBIT Range Over the Past 10 Years
Min: 13.86   Med: 34.86   Max: 141.79
Current: 64.97

During the past 13 years, the highest EV-to-EBIT of Simulations Plus was 141.79. The lowest was 13.86. And the median was 34.86.

SLP's EV-to-EBIT is ranked worse than
92.29% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.57 vs SLP: 64.97

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Simulations Plus's Enterprise Value for the quarter that ended in Feb. 2024 was $721.85 Mil. Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $12.19 Mil. Simulations Plus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 1.69%.


Simulations Plus EV-to-EBIT Historical Data

The historical data trend for Simulations Plus's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.09 94.14 69.32 72.10 66.08

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.87 76.63 66.08 56.88 59.24

Competitive Comparison

For the Health Information Services subindustry, Simulations Plus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Simulations Plus's EV-to-EBIT falls into.



Simulations Plus EV-to-EBIT Calculation

Simulations Plus's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=791.651/12.185
=64.97

Simulations Plus's current Enterprise Value is $791.65 Mil.
Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Simulations Plus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Feb. 2024 ) =EBIT / Enterprise Value (Q: Feb. 2024 )
=12.185/721.85155
=1.69 %

Simulations Plus's Enterprise Value for the quarter that ended in Feb. 2024 was $721.85 Mil.
Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Simulations Plus's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221